DanielC.AdelmanMD

PubMed

• Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.
  Nilsson, C., Vereda, A., Borres, M., Andersson, M., Södergren, E., Rudengren, M., Simon, R., Ryan, R., Fernández-Rivas, M., Smith, A., Adelman, D., Vickery, B.> ;Clinical and Translational Allergy. 2024 Jan 1
• 2 citations
  Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
  Christina Ciaccio, Alan B Goldsobel, Aikaterini Anagnostou, Kirsten Beyer, Thomas B Casale, Antoine Deschildre, Montserrat Fernández-Rivas, Jonathan O'B Hourihane, Mar...> ;Annals of Allergy, Asthma & Immunology. 2022 Dec 1
• 18 citations
  Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
  R Sharon Chinthrajah, Stacie M Jones, Edwin H Kim, Scott H Sicherer, Wayne Shreffler, Bruce J Lanser, Negin Atri, Denise C Babineau, Daniel C Adelman, Ahmar Iqbal, Sus...> ;The Journal of Allergy and Clinical Immunology. 2022 Jun 1
• 9 citations
  Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
  Kari R Brown, James Baker, Andrea Vereda, Kirsten Beyer, A Wesley Burks, George du Toit, Jonathan O'B Hourihane, Stacie M Jones, David Norval, Adrian Dana, Wayne Shref...> ;The Journal of Allergy and Clinical Immunology. 2022 Jun 1
• Reply.
  James Baker, Kirsten Beyer, George du Toit, Wayne Shreffler, Kari R Brown, David Norval, Andrea Vereda, Daniel Adelman, Stacie M Jones, Wesley Burks, Thomas Casale> ;The Journal of Allergy and Clinical Immunology. 2022 Jul 1
• 15 citations
  Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.
  Veronique Bajzik, Hannah A DeBerg, Nahir Garabatos, Blake J Rust, Kimberly K Obrien, Quynh-Anh Nguyen, Colin O'Rourke, Alex Smith, Alex H Walker, Charlie Quinn, Vivian...> ;Allergy. 2022 Aug 1
• 8 citations
  Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy.
  Caroline Nilsson, Amy M. Scurlock, Evan S. Dellon, Joshua M. Brostoff, Trinh Pham, Robert Ryan, Kari R. Brown, Daniel C. Adelman, Seema S. Aceves> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Aug 11
• 28 citations
  Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
  Montserrat Fernandez-Rivas, Andrea Vereda, Brian P. Vickery, Vibha Sharma, Caroline Nilsson, Antonella Muraro, Jonathan O'b Hourihane, Audrey DunnGalvin, George Du Toi...> ;Allergy. 2021 Jul 28
• 18 citations
  Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis
  Nandinee Patel, Daniel C. Adelman, Katherine Anagnostou, Joseph L. Baumert, W. Marty Blom, Dianne E. Campbell, R. Sharon Chinthrajah, E. N. Clare Mills, Bushra Javed, ...> ;The Journal of Allergy and Clinical Immunology. 2021 Feb 9
• 37 citations
  Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
  Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernandez-Rivas, Katharina Blumchen...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 May 1
• 61 citations
  Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled ...
  Jonathan O'b Hourihane, Kirsten Beyer, Allyah Abbas, Montserrat Fernandez-Rivas, Paul Turner, Katharina Blumchen, Caroline Nilsson, Maria D Ibáñez, Antoine Deschildre,...> ;The Lancet. Child & Adolescent Health. 2020 Oct 1
• 19 citations
  Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet
  Jack A. Syage, Peter H.R. Green, Chaitan Khosla, Daniel C. Adelman, Jennifer A. Sealey-Voyksner, Joseph A. Murray> ;Gastrohep. 2019 Nov 1
• 327 citations
  AR101 Oral Immunotherapy for Peanut Allergy
  Brian P. Vickery, Andrea Vereda, Thomas B. Casale, Kirsten Beyer, George Du Toit, Jonathan O'b Hourihane, Stacie M. Jones, Wayne G. Shreffler, Annette Marcantonio, Rez...> ;The New England Journal of Medicine. 2018 Nov 22
• 59 citations
  Measuring Change In Small Intestinal Histology In Patients With Celiac Disease
  Daniel C. Adelman, Joseph A. Murray, Tsung Teh Wu, Markku Mäki, Peter H.R. Green, Ciaran P. Kelly> ;The American Journal of Gastroenterology. 2018 Feb 20
• 8 citations
  A B-cell gene signature correlates with the extent of gluten-induced intestinal injury in celiac disease
  Mitchell Garber, Alok Saldanha, Joel S. Parker, Wendell D. Jones, Katri Kaukinen, Kaija Laurila, Marja-Leena Lähdeaho, Purvesh Khatri, Chaitan Khosla, Daniel C. Adelma...> ;Cellular and Molecular Gastroenterology and Hepatology. 2017 Jan 28
• 51 citations
  Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet.
  Srihari Mahadev, Joseph A. Murray, Tsung-Teh Wu, Vishal S. Chandan, Michael Torbenson, Ciaran P. Kelly, Markku Mäki, Peter H.R. Green, Daniel C. Adelman, B. Lebwohl> ;Alimentary Pharmacology & Therapeutics. 2017 Apr 1
• 17 citations
  A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instru...
  Daniel A. Leffler, Sarah Acaster, Katy Gallop, Melinda Dennis, Ciaran P. Kelly, Daniel C. Adelman> ;Value in Health. 2017 Apr 1
• 77 citations
  No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
  Joseph A. Murray, Ciaran P. Kelly, Peter H.R. Green, Annette Marcantonio, Tsung Teh Wu, Markku Mäki, Daniel C. Adelman, Saqib Hussain Ansari, K. Ayub, A. Basile, C. Be...> ;Gastroenterology. 2017 Mar 1
• 1 citations
  Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters.
  Daniel C. Adelman, Kellee Howard> ;The Journal of Allergy and Clinical Immunology. in Practice. 2016 Nov 1
• 144 citations
  Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease
  Marja-Leena Lähdeaho, Katri Kaukinen, Kaija Laurila, Pekka Vuotikka, Olli-Pekka Koivurova, Tiina Kärjä-Lahdensuu, Annette Marcantonio, Daniel C. Adelman, Markku Mäki> ;Gastroenterology. 2014 Jun 1
• 73 citations
  Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials
  Matthew Siegel, Mitchell Garber, Andrew Spencer, Wendy Botwick, Pawan Kumar, Robert N. Williams, Kenji Kozuka, Revati Shreeniwas, Vijaya S. Pratha, Daniel C. Adelman> ;Digestive Diseases and Sciences. 2012 Feb 1
• 14 citations
  Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer.
  Lee M. Krug, Jeffrey Crawford, David S. Ettinger, Geoffrey I. Shapiro, David R. Spigel, Tony Reiman, Jennifer S. Temel, Glenn Michelson, Donald Y. Young, Ute Hoch, Dan...> ;Journal of Thoracic Oncology. 2011 Feb 1
• 35 citations
  Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.
  Ranjana H. Advani, Herbert Hurwitz, Michael S. Gordon, Scot Ebbinghaus, David S. Mendelson, Heather A. Wakelee, Ute Hoch, Jeffrey A. Silverman, Nancy Havrilla, Craig J...> ;Clinical Cancer Research. 2010 Apr 1
• 82 citations
  A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in p...
  Elisabeth I. Heath, Keith C. Bible, Robert E. Martell, Daniel C. Adelman, Patricia LoRusso> ;Investigational New Drugs. 2008 Feb 1
• 58 citations
  Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
  Jonathan Corren, Gail G. Shapiro, James D. Reimann, Yamo Deniz, Dennis A. Wong, Daniel C. Adelman, Alkis Togias> ;The Journal of Allergy and Clinical Immunology. 2008 Feb 1
• Join now to see all

Lectures

• Clinical immunological society- 2013 Annual Meeting: Regulation & Dysregulation of Immunity 
  Clinical Immunology Society, Miami, Florida - 4/25/2013